Approval · Notice of Compliance 10686 · 2009
ROCURONIUM BROMIDE INJECTION: Notice of Compliance 10686
Issued October 16, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10686
- Date
- October 16, 2009
- Company
- Hospira Healthcare CorporationKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Labelling update
- Therapeutic class
- Non-depolarizing skeletal neuromuscular blocking agent
- Canadian reference product
- ZEMURON (Schering-Plough Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROCURONIUM BROMIDE INJECTION | Not yet assigned | — |
Medicinal ingredients
- ROCURONIUM BROMIDE 10 MG per ML